Accepted answer
Answering this needs the ionisation mode and the mass accuracy, because a low-resolution instrument cannot distinguish several of the shifts that matter.
The UV trace and the total ion chromatogram do not agree, and they should not. UV response depends on the chromophore; MS response depends on ionisation efficiency. A small UV peak can be a large MS peak and vice versa.
Reconciling gross mass to label claim
| Component | Typical share | Counted in purity? | Counted in content? |
|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Mass accuracy decides what the result means. A high-resolution instrument at five parts per million distinguishes a plus-one deamidation from noise; a unit-resolution instrument does not.
High-resolution accurate-mass instruments routinely achieve better than five parts per million, which is what makes single-dalton discrimination possible on a four-kilodalton peptide.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Intact mass rules things out. Fragmentation confirms sequence.
edited 13 May 2025 by deamidation_watch — added the citation requested in comments